The promoter polymorphism may have caused varied concentrations of serum TNF-α, which have been associated with induced sputum in bronchial biopsies and with bronchoalveolar lavage fluid in stable COPD patients and during exacerbations, compared with that of control subjects[25]. This evidence concerns the gene TNF and chronic obstructive pulmonary disease.